Overview

Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was evaluation the efficacy of antiepileptic drug phenytoin (diphenine) in the treatment of bronchial asthma.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre of Chinese Medicine, Georgia
Collaborator:
Rea Rehabilitation Centre, Georgia
Treatments:
Phenytoin
Criteria
Inclusion Criteria:

- Out patients

- Bronchial asthma has been known at least for 1 year

- Absence of long-term remissions of asthma (lasting more than 1 month)

- Poorly controlled asthma, due to various reasons

- Non-smokers

Exclusion Criteria:

- Presence of concomitant acute or chronic severe diseases

- Abnormal baseline haematology, blood chemistry or urinalysis

- Allergy or adverse reactions to investigational drug

- Age younger than 18 years old

- Long-term history of smoking

- Pregnancy or lactating